KalVista Pharmaceuticals, Inc. | Business Contracts

Subscription Agreement, dated as of December 23, 2022, by and among KalVista Pharmaceuticals, Inc. and the purchasers identified on the signature pages thereto (Filed With SEC on December 27, 2022)

Executive Employment Agreement by and between Registrant and Dr. Paul K. Audhya, MD (Filed With SEC on July 13, 2021)

First Amendment of Lease, dated November 20, 2020, to the Office Lease Agreement by and between the Registrant and 55 Cambridge Parkway, LLC, dated May 19, 2017 (Filed With SEC on December 10, 2020)

Amendment, dated June 26, 2019, to the Service Agreement dated November 1, 2015 by and between KalVista Pharmaceuticals Ltd and Dr. Christopher M. Yea (Filed With SEC on July 16, 2019)

Description of the Registrants Securities (Filed With SEC on July 16, 2019)

Form of Pre-Funded Warrant (Filed With SEC on December 27, 2022)

Underwriting Agreement by and among KalVista Pharmaceuticals, Inc. and Jefferies LLC, Stifel, Nicolaus & Company, Incorporated and Cantor Fitzgerald & Co., as Representatives of... (Filed With SEC on February 11, 2021)

Amended and Restated Employment Agreement between the Registrant and T. Andrew Crockett, dated June 26, 2019 (Filed With SEC on July 16, 2019)

Amended and Restated Employment Agreement between the Registrant and Benjamin L. Palleiko, dated June 26, 2019 (Filed With SEC on July 16, 2019)

Amended and Restated Executive Employment Agreement dated June 26, 2019, by and between the Registrant and Andreas Maetzel (Filed With SEC on July 16, 2019)

Amended and Restated Executive Employment Agreement by and between Registrant and Edward Feener (Filed With SEC on July 16, 2019)

Executive Employment Agreement by and between Registrant and Michael Smith (Filed With SEC on July 16, 2019)

Controlled Equity OfferingSM Sales Agreement, by and between KalVista and Cantor Fitzgerald dated March 29, 2019 (Filed With SEC on March 29, 2019)

Amendment, dated January 31, 2019, to the Service Agreement dated November 1, 2015, by and between KalVista Pharmaceuticals Ltd and Dr. Christopher M. Yea (Filed With SEC on March 14, 2019)

Equity Acceleration Letter dated March 11, 2019, by and between KalVista Pharmaceuticals Ltd, and Dr. Christopher M. Yea.# 31.1 Certification of Principal Executive Officer... (Filed With SEC on March 14, 2019)

KalVista Pharmaceuticals, Inc. (15)